-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Akebia Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
- Akebia Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$12.5M, a 4.07% increase year-over-year.
- Akebia Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$34.8M, a 33.7% increase year-over-year.
- Akebia Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$46.3M, a 42.7% increase from 2022.
- Akebia Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$80.8M, a 69.5% increase from 2021.
- Akebia Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$265M, a 30% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)